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Central Message
The STS database is a paradigm-shifting inno-
vation providing participants with opportunities
to improve current and future care quality.
Perspective
The STS database has been a powerful, paradigm-
shifting, disruptive innovation in healthcare. STS
ACSD-participating cardiothoracic surgeons
receive customized reports with comparisons of
their local performance to national benchmarks.
STSACSD has enabled cardiac surgeons and their
heart team members to use highly credible clinical
data in order to assess and improve the quality of
care provided. Moreover, STS ACSD affords a
dynamic,highquality,andcomprehensiveresource
for clinical and health policy research. Using STS
ACSD, surgeon participants actively advance theInitiated in 1989, theSociety of ThoracicSurgeons (STS) Adult CardiacSurgery
Database (ACSD) includes more than 1085 participating centers, representing
90%-95% of current US-based adult cardiac surgery hospitals. Since its
inception, the primary goal of the STS ACSD has been to use clinical data to
track and improve cardiac surgical outcomes. Patients' preoperative risk
characteristics, procedure-related processes of care, and clinical outcomes
data have been captured and analyzed, with timely risk-adjusted feedback
reports to participating providers. In 2006, STS initiated an external audit
process to evaluate STS ACSD completeness and accuracy. Given the
extremely high inter-rater reliability and completeness rates of STS ACSD, it
is widely regarded as the “gold standard” for benchmarking cardiac surgery
risk-adjusted outcomes. Over time, STS ACSD has expanded its quality
horizons beyond the traditional focus on isolated, risk-adjusted short-term
outcomessuchasperioperativemorbidityandmortality.Newquality indicators
have evolved including composite measures of key processes of care and
outcomes (risk-adjusted morbidity and risk-adjusted mortality), longer-term
outcomes, and readmissions. Resource use and patient-reported outcomes
would be added in the future. These additional metrics provide a more
comprehensive perspective on quality as well as additional end points.
Widespread acceptance and use of STS ACSD has led to a cultural trans-
formation within cardiac surgery by providing nationally benchmarked data for
internal quality assessment, aiding data-driven quality improvement activities,
servingas thebasis foravoluntarypublic reportingprogram,advancingcardiac
surgery care through STS ACSDbased research, and facilitating data-driven
informed consent dialogues and alternative treatment-related discussions.
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forefront of knowledge, leaving a legacy for the
future generations of cardiac surgeons.
144 1043-0679/$-see front matter ª 2015 The Authors. Published by Elsevier Inc. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1053/j.semtcvs.2015.07.007
STS ADULT CARDIAC SURGERY DATABASE
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Over the past 25 years, there has been increasing
emphasis on using data-driven approaches to iden-
tify, monitor, report, and improve the quality of care
provided within hospitals and health care delivery
systems. Cardiothoracic surgery has consistently
been at the forefront of this evolutionary paradigm.
This News and Views article provides a brief
summary of the historical development and con-
tinuing innovations of the Society of Thoracic
Surgeons' (STS) Adult Cardiac Surgery Database
(ACSD). We also highlight approaches used to
validate the integrity of STS ACSD data, which are
unparalleled in the health care industry and include
documentation of completeness, accuracy, and reli-
ability. These externally validated, highly accurate
clinical data have been used for a variety of purposes,
including development of sophisticated risk-
adjustment models and performance metrics; feed-
back of benchmarked results to STS ACSD partic-
ipants; data-driven quality improvement activities;
research; government collaborations (eg, device
registries for postmarket surveillance); and data-
based, patient-speciﬁc informed consent and
counseling.
HISTORICAL BACKGROUND
For nearly 3 decades, cardiothoracic surgery has
been the national leader in clinical data registries,
risk adjustment, performance measurement, and
data-driven quality improvement.1 Both the Depart-
ment of Veterans Affairs (VA) and STS began their
activities in these areas in 1986, on separate but
parallel and similar tracks. In 1986, Congress
mandated that the VA must compare risk-adjusted
mortality rates for cardiac surgery with national
standards (Public Law 99-166). Created in 1987,
the ﬁrst nationwide quality improvement national
database initiative was started within the VA and was
titled as “Continuous Improvement in Cardiac
Surgery Program” (CICSP).2 Rather than minimally
complying with this new law's modest reporting
requirements for risk-adjusted outcomes and com-
parative reporting, the CICSP ushered in a new
quality assurance era by producing meaningful local
VA cardiac surgery program-based performance
reports.3
Initiated in direct response to Health Care Financ-
ing Administration's (HCFA, the predecessor of the
Centers for Medicare & Medicaid Services [CMS])
release of inadequately risk-adjusted hospitalic and Cardiovascular Surgery  Volume 27, Numbemortality reports, the STS data registry initiative also
began in 1986. Following this ﬂawed HCFA data
release, STS was inundated by requests for program
quality reviews. The STS issued a statement of
concern in October of that year, starting an ad hoc
Committee on Risk Factors for Coronary Artery
Bypass Surgery.4 In their 1988 report, STS Commit-
tee members emphasized the need to identify and
adjust for all risk factors that were predictive of
operative mortality to make appropriate statistical
comparisons. A data working group led by Dr
Richard Clark was established, and the STS database
was initiated in 1989.5 The fundamental goal of these
early activities was to provide clinically relevant,
timely, accurate, and reliable information to STS
database participants to facilitate their local self-
assessment and self-improvement activities.6-8 By
2013, STS ACSD included 1085 participating sites,
representing 90%-95% of existing US-based adult
cardiac surgery programs.
DATABASE INITIATIVES
Since its inception, a key objective of the STS
ACSD was to assure that the important risk factors
affecting outcomes were captured. This process
always involves a balance between collecting all risk
factors that are even potentially clinically relevant,
which is costly and time consuming, vs collection of
fewer key data elements (or relying on some admin-
istrative or electronic health record [EHR] data),
which reduces data collection burden but potentially
excludes robust adjustment for less common but
important factors.9,10 By the mid-1990s, STS ACSD
standardized data capture forms with uniform def-
initions (including case-based training sample sets)
were distributed, and numerous training opportu-
nities were available for data managers and coordi-
nators. Given the special focus placed on
prospectively inputting high-quality and complete
local-site data, new programs were instituted to
assure data completeness and quality (described
later).11,12
The power of STS ACSD became increasingly
evident to local surgeon participants. As a return
on their own local site's investment, STS providers
received valuable feedback from STS ACSD, helping
them understand their operative and perioperative
processes and outcomes and to facilitate local quality
assurance and improvement activities.13
In 1999, the Duke Clinical Research Institute
(DCRI) was awarded the STS contract for database
warehousing, analysis, and reporting. The DCRIr 2 145
STS ADULT CARDIAC SURGERY DATABASEprovided academic-based faculty expertise related to
database programming, quality control, statistical
analysis, and reporting. Shortly thereafter, the STS
and DCRI established new requirements for software
vendor approval. These approved vendors facilitated
entry of local cardiac surgery programs' data and
transmission of these data to DCRI.
In a collaboration involving the STS Quality
Measurement Task Force and DCRI, risk models
were developed for isolated coronary artery bypass
grafting (CABG) and subsequently for other proce-
dures, including all major isolated valve and valve
plus CABG operations.14-16 In addition, interest
expanded to outcomes beyond 30-day or in-
hospital operative mortality or major morbidity.
New models were developed with a special focus
placed on an expanded set of clinically relevant end
points, including postoperative length of stay, long-
term survival, and readmissions.17-19
In 2007, multidimensional composite measures
were ﬁrst introduced.20,21 They addressed 2 deﬁ-
ciencies of traditional cardiac surgical metrics, which
had focused mainly on postoperative mortality and
which provided inadequate endpoints for analysis.
This limited scope neglected the fact that survival
alone is a necessary but insufﬁcient quality metric,
and that not all short-term survivors have had
equivalent quality care. For example, a patient who
experienced permanent, life-altering, dialysis-
dependent renal failure after surgery has had clearly
a different quality result vs a survivor who experi-
enced no complications. These innovative composite
metrics have evolved to become the preferred STS
method for assessing performance. They include
both risk-adjusted mortality and the risk-adjusted
occurrence for any of 5 major complications (stroke,
renal failure, reoperation, prolonged ventilation, and
sternal infection or mediastinitis). For CABG proce-
dures, moreover, 2 additional process measures were
incorporated: the use of at least 1 internal mammary
artery graft and the use of all 4 National Quality
Forum (NQF)endorsed perioperative medications.
These composite metrics provide a much more
comprehensive assessment of quality than risk-
adjusted mortality alone, and they also increase the
effective sample size and reliability compared to with
individual outcomes measures.20-23
From 1997-2013, the nature and scope of STS
ACSD data elements continued to expand with each
of 5 progressively evolving versions of the STS ACSD
data capture form and deﬁnitions. New and more
granular data elements were added to address
particularly “high-risk” patient characteristics, such
as liver disease and frailty. New registries were also
initiated for postmarket surveillance of new devices,146 Seminincluding the joint STS-ACC Transcatheter Valve
Therapy (TVT) Registry for transcatheter valve
treatment.
Table 1 reviews the major types of variables used in
STS ACSD for CABG-only models for risk-adjusted
30-day operative mortality including (1) patient
demographics, (2) prior cardiac procedures, (3) status
at presentation, (4) comorbidities, (5) primary cardiac
disease severity, (6) general health, (7) preoperative
support, and (8) selected medications.
As the knowledge base continues to expand in
cardiothoracic surgery, STS ACSD has also expanded
the range of risk variables it collects. This facilitates
more accurate performance assessment and
improvement activities, research, patient counseling,
and informed decision-making. Table 1 summarizes
the changes over time in data elements used in
published STS ACSD risk models for CABG.14,24-29
PERFORMANCE IMPROVEMENT
It is important to remember that measurement is
not a goal in itself, but rather a means to an end,
which is improved outcomes and value for cardio-
thoracic surgery patients. The STS National Database
Workforce has added a Task Force on Quality
Initiatives to lead these activities. This Task Force
identiﬁes best practices in important areas of care
(eg, blood conservation and ventilator management)
and disseminates these to ACSD participants
through a variety of modalities, including webinars
and access to key literature. Numerous studies have
now demonstrated marked reductions in cardiac
surgery morbidity and mortality, and improved
adherence to NQF-endorsed process of care practi-
ces, which many believe are directly attributable to
information gleaned from the STS ACSD.28-30
EXTERNAL VALIDATION
The highest recognition for a health care perform-
ance measure is endorsement by the NQF, a multi-
stakeholder public-private partnership with an
extremely rigorous vetting process. As of 2015,
STS has 33 NQF-endorsed performance metrics,
the largest number of any professional society in
the United States. Furthermore, STS ACSD was
designated as a qualiﬁed clinical data registry for
the Physician Quality Reporting System (PQRS), and
this has enabled STS to use many of its own
performance metrics for this program.
PUBLIC REPORTING
In 2010, the STS began a landmark program for
voluntary public reporting of hospital and program-
level results, and these were offered on both the
Consumer Reports and the STS websites.31,32 As ofars in Thoracic and Cardiovascular Surgery  Volume 27, Number 2
Table 1. Comparison of Across STS Models: Risk Factors Affecting Post-CABG Short-Term Mortality by Risk Factor Category
Model Title Edwards
et al24
STS
1990
Model
STS
1991
Model
STS
1992
Model
STS
1993
Model
STS
1994
Model
STS
1995
Model
STS
1996
Model
STS
2000
Model
STS 1997-
1999 Model
STS
2008
Model
Total
Year published 1994 1997 1997 1997 1997 1997 1997 1998 2001 2003 2009
Demographics
Age ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Gender ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Race ★ ★ ★ ★ 4
Prior cardiac procedure
Prior cardiac surgery ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Recent percutaneous coronary
intervention
★ ★ ★ ★ ★ 5
Presentation status
Surgical priority/status ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 10
Hemodynamic instability
(including shock/resuscitation)
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Percutaneous transluminal coronary
angioplasty (PTCA) or percutaneous
coronary intervention
(PCI) accident or emergency
★ ★ 2
Comorbidities
Renal dysfunction ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Chronic lung disease (including
chronic obstructive
pulmonary disease [COPD])
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 10
Peripheral vascular disease (PVD) ★ ★ ★ ★ ★ ★ 6
Cerebrovascular disease (CVD) ★ ★ ★ ★ ★ ★ 6
Diabetes ★ ★ ★ ★ ★ ★ ★ ★ ★ 9
Cerebrovascular accident (CVA) ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Hypertension (systemic) ★ ★ ★ ★ ★ ★ ★ 7
Cardiomegaly ★ ★ ★ ★ ★ 5
Immunosuppressive therapy
(including steroids)
★ ★ ★ ★ ★ ★ ★ ★ 8
Pulmonary hypertension or pulmonary
artery (PA) systolic pressure
★ ★ ★ ★ ★ ★ 6
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Table 1. Continued
Model Title Edwards
et al24
STS
1990
Model
STS
1991
Model
STS
1992
Model
STS
1993
Model
STS
1994
Model
STS
1995
Model
STS
1996
Model
STS
2000
Model
STS 1997-
1999 Model
STS
2008
Model
Total
Year published 1994 1997 1997 1997 1997 1997 1997 1998 2001 2003 2009
Mitral insufﬁciency ★ ★ ★ 3
Aortic stenosis ★ ★ 2
Hypercholesterolemia ★ ★ 2
Severity of cardiac disease
Left ventricular ejection fraction ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ 11
Recent or prior myocardial infarction (MI) ★ ★ ★ ★ ★ ★ 6
New York Heart Association (NYHA) class ★ ★ ★ ★ ★ ★ 6
Left main disease ★ ★ ★ ★ ★ ★ ★ ★ ★ 9
Number of diseased vessels (including 3-
vessel disease)
★ ★ ★ ★ ★ ★ ★ ★ ★ 9
Canadian Cardiovascular Society (CCS)
angina class
★ ★ ★ 3
Arrhythmia (any) ★ ★ ★ ★ ★ ★ 6
Angina (not CCS) ★ ★ ★ 3
Congestive heart failure (CHF) ★ ★ ★ 3
Acute evolving, extending MI ★ ★ 2
Coronary disease ★ 1
General health
Body mass index (BMI), body surface area
(BSA), height and weight, or obesity
★ ★ ★ ★ ★ 5
Preoperative support
Preoperative intraoperative balloon pump
(IABP) or inotropic support or both
★ ★ ★ ★ ★ ★ ★ ★ ★ 9
Intravenous (IV) nitroglycerin ★ ★ 2
Medications
Current diuretic use ★ ★ 2
Current antiplatelet therapy ★ 1
Current digitalis use ★ 1
Notes “Renal Dysfunction” includes any measure of renal function (including creatinine and GFR), dialysis, or renal dysfunction or insufﬁciency. “Arrhythmia (any)” includes both atrial and
ventricular arrhythmias.
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Seminars in Thorac2015, slightly less than half of all STS ACSD
participants consent to public reporting. A similar
program has been initiated using the STS Congenital
Heart Surgery Database, and the STS General Thora-
cic Database plans to offer public reporting in 2016.
These voluntary public reporting programs are
unique in health care and demonstrate the commit-
ment of STS to accountability and transparency.
STS ACSD DATABASE INTEGRITY
In 2006, STS initiated an audit process to evaluate
the completeness and accuracy of STS ACSD. Both
the ACSD and its audit process evolved over the
subsequent years. To assure the accuracy of STS
ACSD data, and to provide credibility and impar-
tiality to our audit process, an external, independent
agency was hired to perform yearly audits of STS
ACSD records from randomly selected participants.
To avoid resampling, STS ACSD participating sites
were eligible for audit only every 3 years. Selected
STS risk variables, especially those included in risk
models, and outcome variables were audited for
accuracy by comparing participant submissions to
the original patient records. The number of STS
ACSD sites audited increased from 24 in 2007 (3%
of sites) to 86 in 2013 (8% of sites). As of 2015, theTable 2. Summary of Audit Process and Overall Finding
Year Sites Audited
(%)
Records
Audited (#)
2006* 24/775 480
(3.09%)
2007* 24/848 459
(2.83%)
2008* 24/971 480
(2.47%)
2009† 29/1004 580
(2.89%)
2010† 40/1028 800
(3.89%)
2011† 51/1051 1020
(4.85%)
2012† 54/1074 1080
(5.03%)
2013† 86/1085 1720
(7.93%)
2014† 108/1090 2160
(10.09%)
*Audit included CABG-only records.
†Audit included CABG and valve records.
ic and Cardiovascular Surgery  Volume 27, Numbeaudit included 10% of STS ACSD participating sites.
Across all variable categories (Table 2), the aggregate
agreement rates for more than 100,000 data ele-
ments audited each year across multiple sites ranged
from 94.5% (2007) to 97.2% (2012). The Figure
illustrates the variable-speciﬁc agreement trends over
the past 9 years. Although the operative mortality
agreement was lower in the early years, this agree-
ment rate has remained more than 95% since 2008.
Feedback from audited sites has been consistently
positive, with most participants believing that the
audit process improved their future STS ACSD data
submission accuracy.
Over time, the external audits documented con-
tinued improvements in STS ACSD reliability. Given
the random sampling process used for the audit's site
selection, as well as the high degree of accuracy
demonstrated, all stakeholders (eg, surgeons, health
care insurers, regional quality organizations, and
policy makers) using STS ACSD analyses should be
extremely conﬁdent about the data, analyses, and
benchmarked ratings in these reports.
RESEARCH OPPORTUNITIES
Today's medical research landscape is dynamic,
and parallels the rapid advancements in biomedicals
Variables
Reabstracted (#)
Overall Agreement
(%)
62 25005/16435
94.6%
62 23926/25318
(94.5%)
62 25466/26540
(95.95%)
75 30008/31228
(96.09%)
75 41341/43129
(95.85%)
73 52720/54737
(96.32%)
74 57479/59132
(97.21%)
72 92991/96259
(96.60%)
74 121662/127087
(95.73%)
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Figure. STS ACSD Audit Findings (2006-2014). (Color version of ﬁgure is available online at http://www.
semthorcardiovascsurg.com.)
STS ADULT CARDIAC SURGERY DATABASEsciences and health services research relevant to the
organization, delivery, ﬁnancing, and reimburse-
ment of health care. There is increasing focus on
how best to optimize patient outcomes and achieve
cost-effective care—not just in the short-term, in-
hospital, or 30-day time frame following a cardiac
surgical procedure, but also long-term survival and
freedom from rehospitalizations and reinterventions.
Importantly, a formal STS Research Center was
established in 2011. Since then the Research Center
has evaluated numerous grant proposals and has
achieved federal funding for 14 grants.
The STS has successfully linked their databases
with other data resources, which further expands its
research capabilities to address important health
policy questions.33,34 Additionally, efforts are
ongoing to transform the STS ACSD into a platform
for longitudinal follow-up. This facilitates longitudi-
nal assessment of outcomes and performance, com-
parative effectiveness research, device surveillance,
and analysis of the economics of health care.18,33-35
Since its inception, numerous scientiﬁc and health
policy publications have been derived from STS
ACSD. Across a diversity of high-impact journals
and textbooks, cardiothoracic surgery knowledge has
been signiﬁcantly advanced by STS ACSD, including
the tracking of use and evaluation of newer treatment
approaches and modalities such as off-pump
CABG,36 endoscopic vein harvest,37 and less invasive
valve surgery.38 Beyond their intrinsic research value,
these efforts have also enhanced the capability and
credibility of STS ACSD by facilitating new and
important collaborations with other professional
associations, industry, and regulatory bodies. These
include introduction of postmarket surveillance for150 Seminnew medical devices and therapies, as exempliﬁed by
the TVT Registry. This landmark clinical data repo-
sitory for transcatheter valve replacement and repair
procedures was developed as a collaborative
endeavor between the STS and the American College
of Cardiology, with extensive involvement from the
Food and Drug Administration (FDA).
The STS and DCRI have provided a combined
research infrastructure supportive of continued lead-
ership in research, including important oversight
provided by the STS Access and Publication Task
Force. STS members and leadership contribute their
knowledge and expertise to develop, reﬁne, and
implement studies that address important research
questions. With the STS databases serving as a “gold
mine” of resources, STS leadership is committed to
supporting clinical research as a fundamental strat-
egy to advance the future of cardiothoracic care.39
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